ArticleBMC cancer2025

Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ductal adenocarcinoma.

Rasmus S Pedersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.